1. Home
  2. EPSM vs AIMD Comparison

EPSM vs AIMD Comparison

Compare EPSM & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EPSM

Epsium Enterprise Limited Ordinary Shares

HOLD

Current Price

$1.06

Market Cap

18.7M

Sector

N/A

ML Signal

HOLD

AIMD

Ainos Inc.

HOLD

Current Price

$1.78

Market Cap

17.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EPSM
AIMD
Founded
2010
1984
Country
China
United States
Employees
13
41
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.7M
17.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EPSM
AIMD
Price
$1.06
$1.78
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
75.6K
869.8K
Earning Date
04-29-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.04
$0.45
52 Week High
$155.00
$4.50

Technical Indicators

Market Signals
Indicator
EPSM
AIMD
Relative Strength Index (RSI) 39.24 47.67
Support Level N/A $1.55
Resistance Level $1.49 $2.51
Average True Range (ATR) 0.19 0.47
MACD 0.01 -0.01
Stochastic Oscillator 27.42 18.48

Price Performance

Historical Comparison
EPSM
AIMD

About EPSM Epsium Enterprise Limited Ordinary Shares

Epsium Enterprise Ltd is a holding company and conducts business through its subsidiaries. It is engaged in import trading and wholesale selling of beverages in Macau. The company imports and sells a range of beverages, alcoholic beverages, and a small quantity of tea and fruit juice. The alcoholic beverages it sells include Chinese liquor, French cognac, Scottish whiskey, fine wine, Champagne, and other miscellaneous beverage alcohol.

About AIMD Ainos Inc.

Ainos Inc is a dual-platform company advancing artificial intelligence based smelltech technologies and immune therapeutics. Its primary strategic focus is the commercialization of its proprietary scent digitization platform, AI Nose, while the company also continue to develop therapeutic assets based on its low-dose oral interferon program, VELDONA. Its core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial intelligence models, which it refers to as a smell language model (SLM), to digitize scent and volatile organic compound (VOC) signals into Smell ID, a machine-readable data format.

Share on Social Networks: